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INTRODUCTION
Serum albumin concentration (SAC) is a classical representative
marker of nutritional status, generating oncotic pressure and work-
ing as antioxidants (1). Decreased serum albumin is associated
with rapid loss of kidney function in patients with chronic kidney
disease (CKD) all over the world (2, 3). Therefore, the increase
of SAC is one of the therapeutic goals in the management of CKD
patients (4).
SAC is affected by many factors. One of these factors includes
postural change (5). SAC is significantly modified by postural
change- induced plasma volume distribution and the relative gap
of gravitational force. Statistically significant differences of SAC
from supine to sitting or standing posture were found, and SAC
taken in a standing posture is approximately 10% higher than that
in a supine position. In addition, changes in SAC are caused by
health condition and comorbidities. Organ dysfunction has a direct
relationship with SAC, because albumin is produced in the liver
and abnormally excreted in urine or feces only when the kidney or
bowel is damaged. Thus, liver function, proteinuria, and protein-
losing gastrointestinal disorders can govern albumin concentra-
tion. Moreover, food intake can influence on SAC (6). However,
to our knowledge, no one has evaluated the primary determinants
for SAC in CKD patients around hospitalization, who take low-
protein diet and receive glucocorticoid administration.
Therefore, in this study, we investigated the time course of SAC
in hospitalized CKD patients to determine whether it can serve as
an indicator to decide the discharge of hospitalized patients. We
also focus on the amount of proteinuria around hospitalization,
which is a unique and influential factor on SAC in CKD patients
to investigate how critical the amount of proteinuria is for SAC.
PATIENTS AND METHODS
Ethics statement
All clinical investigations were conducted according to the prin-
ciples expressed in the Declaration of Helsinki. This study was
approved by the Research Ethics Committee of Tokushima Uni-
versity.
Study design and subjects
This study is a retrospective study. Study flow diagram is
shown in Figure 1. The subjects initially enrolled in this study met
the following criteria ; 1) hospitalization for ten or more days in
Tokushima University Hospital from 2012 to 2015 ; 2) eating more
than 90% of served hospital foods ; 3) without significant infection,
organ failure, gastrointestinal bleeding or malignancy. Next, CKD
patients who took all of the blood and urine examination of SAC,
hemoglobin, urine protein, urine creatinine at the last outpatient
check-up before hospitalization (A point), on the second day of
hospitalization (B point), at the last laboratory examination before
discharge from the hospital (C point), as well as at the first out-
patient follow-up after discharge (D point) were selected. Finally,
patients were divided into groups based on those who had less than
1 g/gCreatinine proteinuria (low proteinuria) with glucocorticoid
only/and immunosuppressant treatment during hospitalization
(LPG group), those who had 1 or more g/gCreatinine proteinuria
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(high proteinuria) without glucocorticoid/immunosuppressant
treatment during hospitalization (HP group), and those who had
1 or more g/gCreatinine proteinuria (high proteinuria) with glu-
cocorticoid only/and immunosuppressant treatment during hos-
pitalization (HPG group). Of note, we excluded the patients with
biopsy-proven minimal change nephrotic syndrome from HPG
group, because it is common to have complete remission of pro-
teinuria and rapid increase of SAC in this condition. All patients
involved ate hospital food, which included 1600 to 2000 kcal with
0.6 to 1.0 g of protein/kg of idealistic body weight and less than 5 g
of salt.
The reference group (REF group) to the registered CKD pa-
tients consisted of patients who took all of the blood examinations
of SAC and hemoglobin at A, B, C, and D points and whose prote-
inuria was less than 30 mg/dl by dipstick urine test with an esti-
mated glomerular filtration rate over 45 ml/min/1.73 m2 (7). Their
meal included 1600 to 2200 kcal with 1.2 to 1.4 g of protein/kg of
idealistic body weight protein and less than 10 g of salt.
Demographic and clinical characteristics of enrolled patients at
A were acquired. The values of hemoglobin, SAC, serum creatinine,
urine protein, urine creatinine and clinic blood pressure (8) at A,
B, C, and D were collected. At A and D in outpatient division, blood
was collected in a sitting position, while at B and C, in sitting or
supine positions. Blood samples were taken between six and seven
o’clock in the morning before breakfast during hospitalization.
SAC was measured by a modified BCP method (9). Urine creatinine
was determined by an enzymatic method (10). Urine protein was
measured by a dye-binding colorimetric method utilizing pyrogal-
lol red-molybdate complex (11).
Statistical analysis
All values are expressed as meanSD. Statistical analysis was
performed using SPSS for Windows version 13.0 (SPSS, Inc.,
Chicago, IL, USA). Baseline characteristics between CKD and REF
patients were compared using student’s t - test or Welch’s t - test,
if data were normally distributed. Non-normal data were analyzed
by Man-Whitney’s U test. F-test was used for comparing the fac-
tors of total deviation. Prevalence data were analyzed by means of
chi -square or Fisher’s exact probability test. The changesof sero-
logical and clinical parameters in the observation period were ana-
lyzed using pairedt- test or Wilcoxon signed-ranks test, as appro-
priate. Significance was defined by P less than0.05.
RESULTS
Demographic and clinical characteristics
Basic characteristics were shown in Tables 1 and 2. Most of the
patients in the REF group were hospitalized due to a cerebrovas-
cular disease with mild motor and/or sensory disturbance or neu-
ritis. They had relatively normal kidney function and no anemia.
The majority of the LPG group patients suffered from biopsy-proven
IgA nephropathy receiving three-week serial steroid pulse therapy
(12). These patients were the youngest and had the lowest blood
pressure among groups. The HP group consisted of educational
hospitalization patients to manage hypertension, blood sugar con-
trol, or edema (13). These subjects were the oldest and had the
highest blood pressure and the worst kidney function among all
groups. The HPG group patients needed steroid and/or immuno-
suppressant therapy because of biopsy-proven kidney diseases,
such as membranous nephropathy and lupus nephritis. They had
the longest duration of hospitalization among groups. Of note, ba-
sically, A/G ratios were inversely related to SAC while A/G ratios
in the HP and HPG groups were significantly lower than those in
the REF and LPG groups probably because of proteinuria. These
results suggested that general conditions including inflammation
and nutrition were similar between the REF and LPG groups or
between the HP and HPG groups.
SAC in the REF group
Figure 2 shows the change of SAC and hemoglobin in the REF
group. SAC decreased significantly at B compared to A (when
hospitalized) and increased significantly at D compared to C (after
hospital discharge). The time course of SAC was similar as that of
hemoglobin. The decrease of SAC mean value at B (3.60 g/dl) was
8.6% compared to A (3.94 g/dL). The increase of SAC mean value
at D (4.03 g/dL) was 15.3% compared to C (3.49 g/dL).
Figure 1. Evaluation point and enrollment of subjects analyzed in this
study
(A, B) The subjects initially enrolled in this study met the following cri-
teria ; 1) hospitalization for ten or more days in Tokushima University
Hospital ; 2) eating more than 90% of served hospital foods ; 3) without
significant infection, organ failure, gastrointestinal bleeding or malig-
nancy. Next, CKD patients who took all of the blood and urine exami-
nation at the last outpatient check-up before hospitalization (A point),
on the second day of hospitalization (B point), at the last laboratory ex-
amination before discharge from the hospital (C point), at the first out-
patient follow-up after discharge (D point) were selected. Finally, pa-
tients were divided into groups based on those who had less than 1 g/
gCreatinine proteinuria (low proteinuria) with glucocorticoid only/and
immunosuppressant treatment during hospitalization (LPG group),
those who had 1 or more g/gCreatinine proteinuria (high proteinuria)
without glucocorticoid/immunosuppressant treatment during hospitali-
zation (HP group), and those who had 1 or more g/gCreatinine protein-
uria (high proteinuria) with glucocorticoid only/and immunosuppressant
treatment during hospitalization (HPG group). The patients with biopsy-
proven minimal change nephrotic syndrome were excluded.
The reference group (REF group) consists of patients who took all of the
blood examination at A, B, C, and D and whose proteinuria was less than
30 mg/dl by dipstick urine test with an estimated glomerular filtration
rate over 45 ml/min/1.73 m2.
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Table 1. Principal disease, comorbidity and drug profile of the patients enrolled.
REF (1) LPG (2) HP (3) HPG (4)





























DM (%) 8 (27.6%)2,4 2 (7.1%)1,3 16 (44.4%)2,4 1 (2.5%)1,3
HT (%) 14 (48.3%)3 12 (42.9%)3 36 (100%)1,2,4 24 (60.0%)3
Treatment
GC start (%) 5 (17.2%)2,3,4 25 (89.3%)1,3 0 (0.0%)1,2,4 35(87.5%)1,3
GC inc. (%) 1 (3.4%) 1 (3.6%) 0 (0.0%)4 5 (12.5%)3
GC user (%) 9 (31.0%)2,3,4 28 (100%)1,3 0 (0.0%)1,2,4 40 (100%)1,3
Drug
DM (%) 4 (13.8%) 1 (3.6%)3 12 (33.3%)2,4 2 (5.0%)3
Anti -HT (%) 8 (27.6%)3,4 12 (42.9%)3 32 (88.9%)1,2,4 22(55.0%)1,3
Statin (%) 5 (17.2%) 4 (14.3%) 10 (27.8%) 8 (20.0%)
Anti -UA (%) 1 (3.4%)3 5 (17.9%) 12 (33.3%)1 6 (15.0%)
GC (%) 4 (13.8%)3 3 (10.7%) 0 (0.0%)1,4 5 (12.5%)3
IS (%) 1 (3.4%) 1 (3.6%) 1 (2.8%) 3 (7.5%)
ESA (%) 0 (0.0%)3 2 (7.1%) 5 (13.9%)1 3 (7.5%)
DM : Diabetes mellitus. HT : Hypertension. GC start/inc. : Glucocorticoid was started/increased during hos-
pitalization. UA : Uric acid. IS : Immunosuppressant. ESA : Erythropoiesis -stimulating agent. CVD : Cere-
brovascular disease. MG : Myasthenia Gravis. IgAN : IgA nephropathy. ANCA : ANCA-related nephritis.
Lupus : Lupus nephritis. IN : Interstitial nephritis. MPGN : Membranoproliferative glomerulonephritis.
IgG4 : IgG4-related kidney disease.CholE : Cholesterol embolism. NSCL : Nephrosclerosis. MN : Membra-
nous nephropathy. Cryo : Cryoglobulin nephropathy. Superscript1,2,3,4 : Significantly different from 1, 2, 3, 4.
Table 2. Demographic and clinical characteristics of the patients enrolled.
REF (1) LPG (2) HP (3) HPG (4)
Patients (n) 29 28 36 40
Age (years) 54.317.62,3 40.820.21,3,4 66.814.51,2,4 56.218.52,3
Female (%) 8 (27.6%) 13 (46.4%) 14 (38.9%) 15 (37.5%)
BMI (kg/m2) 22.43.6 21.43.4 22.64.3 22.43.4
DurHos (day) 25.920.54 29.921.74 24.814.94 48.524.71,2,3
SBP (mmHg) 130222,3 119141,3,4 152251,2,4 131172,3
DBP (mmHg) 76.115.7 71.38.94 79.318.4 78.311.92
WBC (103/μl) 7.512.60 6.412.12 6.702.43 7.353.58
Hb (g/dL) 14.51.52,3,4 12.72.11,3 11.32.11,2,4 12.62.91,3
Plt (104/μl) 24.96.2 25.86.1 24.38.5 26.27.2
GOT (U/L) 23.98.42 16.44.11,4 19.68.8 21.57.62
GPT (U/L) 21.111.42,3,4 13.57.21 12.56.21 14.96.01
LDH (U/L) 218752,3 173331,3,4 252701,2,4 208372,3
ALP (U/L) 246962 190601,3 240842 21170
TP (g/dL) 7.080.623,4 7.200.533,4 6.170.771,2 5.911.191,2
Alb (g/dL) 3.940.253,4 3.910.353,4 2.870.621,2 2.610.681,2
A/G ratio 1.260.223,4 1.150.283,4 0.870.201,2 0.790.211,2
BUN (mg/dL) 13.45.63,4 19.413.93 38.624.61,2,4 24.115.61,3
Cre (mg/dL) 0.740.212,3,4 1.371.321,3 2.702.001,2,4 1.611.191,3
UA (mg/dL) Not available 5.701.673,4 7.452.092 6.812.082
Na (mEq/L) 140.12.53,4 141.02.6 141.73.81 141.62.31
K (mEq/L) 4.170.46 4.290.32 4.130.64 4.320.64
Cl (mEq/L) 103.52.72,3,4 104.92.41 105.65.81 106.13.11
Tcho (mg/dL) 195294 180293,4 210572 245921,2
TG (mg/dL) 1781522 110551,3,4 1781172 1911792
HDL (mg/dL) 61.217.1 57.117.7 55.013.5 59.821.1
UP (g/gCr) Not available 0.520.283,4 6.413.742 5.313.832
BMI : Body mass index. DurHos : Duration of hospitalization. SBP : Systolic blood pressure. DBP : Diastolic
blood pressure. UP : Urine proteinuria.
Superscript1,2,3,4 : Significantly different from 1, 2, 3, 4.
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SAC and proteinuria in the LPG group
SAC and proteinuria in CKD patients with low proteinuria re-
ceiving steroid/immunosuppressant therapy (LPG group) were
investigated. SAC decreased significantly and continuously from
A to C, but increased at D significantly. The movement of SAC was
similar from A to B and C to D with that of hemoglobin. In this
group, SAC became lower significantly from B to C and it was dif-
ferent from the REF group. Meanwhile, proteinuria decreased sig-
nificantly and continuously from A to C. At D, proteinuria became
lower, but not reaching statistical significance (Figure 3).
SAC and proteinuria in the HP group
SAC and proteinuria in CKD patients with high proteinuria but
who were not using steroid/immunosuppressant therapy (HP
group) were evaluated. SAC and hemoglobin decreased from A
to B and increased from C to D significantly, as well as those in the
REF and LPG groups. Conversely, a moderate but statistically
significant increase of SAC from B to C (during hospitalization)
was observed. SAC at D became significantly higher than that at
A. As for proteinuria, a significant decrease was detected from A
to C, as well as that in the LPG group. However, at D, proteinuria
increased significantly compared with that at C. The time course
of proteinuria was irrelevant with that of SAC (Figure4).
SAC and proteinuria in the HPG group
SAC and proteinuria in CKD patients with high proteinuria using
steroid/immunosuppressant therapy (HPG group) were analyzed.
The movements of SAC and proteinuria were basically similar with
those in the HP group. However, at D, proteinuria was not signifi-
cantly lower than that at C, even with glucocorticoid treatment. It
was similar with that in the LPG group (Figure 5).
Time course of systolic blood pressure
Proteinuria decreased significantly at B in CKD patients (Figure
3, 4, 5) and increased significantly at D in the HP group (Figure 4).
In order to clarify the reason why proteinuria decreased during hos-
Figure 2. Serum albumin and hemoglobin concentration in the refer-
ence group
(A) Serum albumin concentration decreased significantly at B compared
to A and increased significantly at D compared to C. (B) The time course
of hemoglobin concentration was similar as that of serum albumin con-
centration. Dots are the values of patients. Horizontal bar shows mean
value. *P0.01. **P0.05.
Figure 3. Serum albumin, hemoglobin concentration and proteinuria
in chronic kidney disease patients with low proteinuria (LPG group)
(A) Serum albumin concentration decreased significantly and continu-
ously from A to C, but increased at D point significantly. (B) The move-
ment of hemoglobin concentration was similar from A to B and C to D
with that of serum albumin concentration. (C) Proteinuria decreased
significantly and continuously from A to C. Dots are the values of patients.
Horizontal bar shows mean value. *P0.01. **P0.05.
Figure 4. Serum albumin, hemoglobin concentration and proteinuria
in chronic kidney disease patients with high proteinuria without gluco-
corticoid therapy (HP group)
(A) Serum albumin concentration decreased from A to B and increased
from C to D significantly. Significant increase of serum albumin concen-
tration from B to C was also observed. Serum albumin concentration at
D became significantly higher than that at A. (B) Hemoglobin concen-
tration decreased from A to B and increased from C to D significantly.
(C) Significant decrease of proteinuria was detected at B compared to
A. Proteinuria continue to decrease from B to C, but it increased sig-
nificantly from C to D. Dots are the values of patients. Horizontal bar
shows mean value. *P0.01.
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pitalization, we investigated the change of systolic blood pressure.
In all groups, systolic blood pressure improved at B and increased
at D significantly (Figure 6).
DISCUSSION
In this study, we investigated the influential factors of SAC in
CKD patients during and immediately after hospitalization. Unex-
pectedly, the time course of SAC was not consistent with that of
proteinuria, even in patients with high proteinuria. The improve-
ment of SAC during hospitalization in CKD patients with high
proteinuria was significant, but similar with that after discharge
from the hospital. Thus, SAC was affected by many factors such as
postural change, activity, treatment, meals, as well as proteinuria.
SAC is a classical prognostic factor in general, so it should be ana-
lyzed while standardizing a patient’s condition during phlebotomy.
Proteinuria was affected partly by blood pressure, even with edu-
cational and therapeutic intervention.
The novel finding in this study is the relationship between SAC
and proteinuria in CKD patients immediately after hospitalization
(from A to B) and after discharge from the hospital (from C to D).
For example, minimal change disease patients usually have mas-
sive proteinuria and glucocorticoid therapy induces quick and
complete remission of proteinuria, followed by an increase of SAC.
Therefore, we hypothesized that the amount of proteinuria is the
major determinant of SAC in CKD patients with high proteinuria
(the HP and HPG groups). However, the changes of SAC and pro-
teinuria from A to B and from C to D were not consistent with our
hypothesis. Considering the REF and LPG groups, a patient’s
posture had a role in SAC change just after hospitalization and after
hospital discharge, because SAC in a sitting position show at most
a 5% increase compared with that in a supine position (5). However,
the difference of SAC was greater than the value expected by pos-
tural change. We assume that the increase of physical activity and
change of food at home can have an additional effect on SAC (14,
15) as hospitalized patients do not move as much as they typically
do at home, and their food was restricted to hospital supply. Thus,
postural change, physical activity, and food can be a more powerful
factor for SAC than proteinuria at home, even in CKD patients with
high proteinuria.
SAC during hospitalization (from B to C) was inversely related
to proteinuria in the HP and HPG groups. The improvement of SAC
was caused by the decrease of proteinuria, but the change was
moderate and similar as compared to A and as was seen after hos-
pital discharge (D). Unexpectedly, SAC decreased in the LPS group
significantly during hospitalization. The REF group also experi-
enced SAC decrease in hospitalization, but not significantly. This
can be also explained by the decrease of physical activity. There
is some possibility that low-protein diet and glucocorticoid therapy
worsen the value of SAC in the LPG group (16). The evidence to
show the effect of glucocorticoid on albumin synthesis is extremely
scarce, especially when glucocorticoid is used in non- inflammatory
disease patients (17). Glucocorticoid increases albumin synthesis
in liver hepatocyte in vitro (18). However, to our knowledge, we
do not have definitive data to clarify the glucocorticoid effect on
SAC in vivo. Further investigation is needed to determine the glu-
cocorticoid effect on liver albumin synthesis in CKD patients. Thus,
our results suggest that hospitalization is not a preferable condition
in terms of SAC. Taken together, we do not need to postpone hos-
pital discharge because of relatively low SAC.
In our study, proteinuria improved just after hospitalization in
CKD patients and worsened after hospital discharge in the HP
group. We found that the change of systolic blood pressure was
consistent with the amount of proteinuria. Ogi et al. reported that
Figure 5. Serum albumin, hemoglobin concentration and proteinuria
in chronic kidney disease patients with high proteinuria with glucocor-
ticoid therapy (HPG group)
(A) Serum albumin concentration decreased from A to B and increased
from C to D significantly. Significant increase of serum albumin concen-
tration from B to C was also observed. Serum albumin concentration at
C and D became significantly higher than that at A. (B) Hemoglobin
concentration decreased from A to B significantly. It increased from C
to D, but not reaching significant difference. (C) Significant decrease of
proteinuria was detected continuously from A to C. Dots are the values
of patients. Horizontal bar shows mean value. *P0.01. **P0.05.
Figure 6. Time course of systolic blood pressure
(A) Reference group ; (B) LPG group ; (C) HP group ; (D) HPG group.
Systolic blood pressure improved from A to B and increased from C to
D significantly in all groups. Dots are the values of patients. Horizontal
bar shows mean value. *P0.01. **P0.05.
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a supine position induces higher blood pressure, better creatinine
clearance and sodium excretion, and less renin activity and al-
dosterone concentration temporarily compared to a standing po-
sition in CKD patients (19). However, in reality, the effect of hos-
pitalization to stabilize blood pressure could overcome temporal
postural change and decrease proteinuria just after hospitalization.
The worsening after hospital discharge can also be explained by
food change and physical activity. Dietary change can influence on
the amount of proteinuria (20, 21). Excessive exercise can increase
proteinuria temporarily (22), while modest exercise has a prefer-
able effect on proteinuria in patients with stable CKD (23).
Hemoglobin decreased just after hospitalization and increased
after hospital discharge in all groups. This can be explained by
postural change. Physical activity also played a role in the change
of hemoglobin concentration (24). During hospitalization, the move-
ment of hemoglobin concentration was variable, maybe because
of a lot of influential factors including kidney function and erythro-
poietin usage.
A weakness of this study is its relatively small sample size. In
addition, there were quite a few patients who had less than 1 g/
gCreatinine proteinuria without glucocorticoid only/and immuno-
suppressant treatment during hospitalization. Therefore, we could
not investigate the effects of hospitalization on SAC in such pa-
tients. Other limitations included the lack of optimal control sub-
jects whose age, hospitalized duration, food, disease and therapeutic
drugs were adjusted to each CKD group. Therefore, a “reference”
group was established to show the effect of postural change and
hospitalization on clinical parameters.
In summary, in this study, we demonstrate that SAC was affected
by not only proteinuria, but also postural change and physical ac-
tivity in hospitalized CKD patients. Food change and content of
therapy probably played a role in SAC. Proteinuria decreased sig-
nificantly just after hospitalization and the worsening of proteinuria
after hospital discharge could be secondary to multiple causes,
partly due to blood pressure. Thus, SAC is an important prognostic
factor. However, even with educational and therapeutic interven-
tion, the improvement of SAC during hospitalization was moderate.
We can expect significantly higher SAC in the first outpatient follow-
up appointment compared with that before hospitalization even in
CKD patients.
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